ProfileGDS4718 / 214229_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 49% 53% 48% 53% 47% 49% 48% 51% 49% 52% 50% 45% 51% 50% 55% 54% 51% 52% 54% 52% 55% 48% 51% 48% 50% 55% 51% 50% 42% 50% 55% 49% 54% 51% 50% 54% 49% 50% 53% 51% 50% 54% 47% 63% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4479849
GSM549102patient 115, normal, homogenized [OPG study]5.7124853
GSM549104patient 119, normal, homogenized [OPG study]5.3848848
GSM549108patient 138, normal, homogenized [OPG study]5.7046653
GSM549119patient 077, normal, homogenized [OPG study]5.3475147
GSM549133patient 032, cancer, homogenized [OPG study]5.4279749
GSM549139patient 042, cancer, homogenized [OPG study]5.3900948
GSM549099patient 107, normal, homogenized [OPG study]5.5674551
GSM549109patient 139, normal, homogenized [OPG study]5.4806949
GSM549110patient 046, normal, homogenized [OPG study]5.6225852
GSM549114patient 063, normal, homogenized [OPG study]5.4461650
GSM549122patient 082, normal, homogenized [OPG study]5.2316545
GSM549134patient 033, cancer, homogenized [OPG study]5.5526251
GSM549136patient 036, cancer, homogenized [OPG study]5.4440250
GSM549140patient 044, cancer, homogenized [OPG study]5.7510155
GSM549111patient 047, normal, homogenized [OPG study]5.7202754
GSM549113patient 057, normal, homogenized [OPG study]5.5439551
GSM549132patient 031, cancer, homogenized [OPG study]5.6355552
GSM549137patient 038, cancer, homogenized [OPG study]5.7513954
GSM549142patient 047, cancer, homogenized [OPG study]5.7566152
GSM549100patient 110, normal, homogenized [OPG study]5.8034455
GSM549107patient 135, normal, homogenized [OPG study]5.3667848
GSM549115patient 068, normal, homogenized [OPG study]5.5228451
GSM549116patient 072, normal, homogenized [OPG study]5.3993848
GSM549120patient 078, normal, homogenized [OPG study]5.5346750
GSM549131patient 030, cancer, homogenized [OPG study]5.7781155
GSM549118patient 074, normal, homogenized [OPG study]5.560151
GSM549129patient 027, cancer, homogenized [OPG study]5.5315150
GSM549123patient 088, normal, homogenized [OPG study]5.0585642
GSM549124patient 006, cancer, homogenized [OPG study]5.5480350
GSM549126patient 015, cancer, homogenized [OPG study]5.7866355
GSM549128patient 025, cancer, homogenized [OPG study]5.4412449
GSM549103patient 117, normal, homogenized [OPG study]5.7687954
GSM549117patient 073, normal, homogenized [OPG study]5.5491751
GSM549138patient 041, cancer, homogenized [OPG study]5.4997550
GSM549141patient 045, cancer, homogenized [OPG study]5.7062154
GSM549130patient 028, cancer, homogenized [OPG study]5.4319949
GSM549101patient 111, normal, homogenized [OPG study]5.5614250
GSM549105patient 128, normal, homogenized [OPG study]5.6792653
GSM549106patient 134, normal, homogenized [OPG study]5.5384351
GSM549112patient 048, normal, homogenized [OPG study]5.4996750
GSM549125patient 011, cancer, homogenized [OPG study]5.7615754
GSM549127patient 024, cancer, homogenized [OPG study]5.3386147
GSM549135patient 035, cancer, homogenized [OPG study]6.3118563